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Calcium sensing receptor (CaSR), isolated for the first time from bovine and human
parathyroid, is a G-protein-coupled receptors that has been involved in diverse
physiological functions. At present a complete in vivo work on the identification of CaSR
mRNA-expressing cells in the adult brain lacks and this investigation was undertaken in
order to acquire more information on cell type expressing CaSR mRNA in the rat brain and
to analyse for the first time its expression in different experimental models of brain injury.
The expression of CaSR mRNAs was found mainly in scattered cells throughout almost all
the brain regions. A double labeling analysis showed a colocalization of CaSR mRNA
expression in neurons and oligodendrocytes, whereas it was not found expressed both in
the microglia and in astrocytes. One week after kainate-induced seizure CaSR was found in
the injured CA3 region of the hippocampus and very interestingly it was found up-
regulated in the neurons of CA1–CA2 and dentate gyrus. Similarly, 1 week following
ibotenic acid injection in the hippocampus, CaSR mRNA expression was increased in
oligodendrocytes both in the lesioned area and in the contralateral CA1–CA3 pyramidal cell
layers and dentate gyrus. One week after needle-induced mechanical lesion an increase of
labeled cells expressing CaSR mRNA was observed along the needle track. In conclusion,
the present results contribute to extend available data on cell type-expressing CaSR in
normal and injured brain and could spur to understand the role of CaSR in repairing
processes of brain injury.
© 2009 Elsevier B.V. All rights reserved.
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1. Introduction
Calcium sensing receptor (CaSR) has been isolated for the first
time from bovine and human parathyroid glands (Brown,
1991; Garrett et al., 1995), and later from rat brain (Ruat et al.,
1995). The CaSR is predicted to be glycosylated proteins, with a
large extracellular domain and the sevenmembrane spanning
region characteristic of other G-protein-coupled receptors
(Brown, 1991; Garrett et al., 1995; Riccardi et al., 1995), and it
has been involved in diverse physiological functions (Chatto-
padhyay and Brown, 2000). Localization of transcripts for CaSR
in the adult rat brain has been reported by Rogers KV and
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coworkers (1997), and more recently by Ferry et al. (2000),
which performed an analysis of CaSRmRNA expression in the
adult brain and its localization in neurons and oligodendro-
cytes. CaSR has been also found express both in astrocytes and
microglia but these results have been achieved using primary
cultures of human and rat brain respectively (Chattopadhyay
et al., 1999, 2000). Therefore, at present, a complete in vivo
work on the identification of CaSR mRNA-expressing cells
lacks and this study was undertaken in order to acquire more
information on cell type expressing CaSR mRNA in the rat
brain and to analyse for the first time the CaSR mRNA ex-
pression in different experimental models of brain injury: (a)
bilateral lesion of hippocampal CA3 regions by kainate-
induced seizure; (b) unilateral hippocampal lesion by a stereo-
taxic local injection of ibotenic acid; (c) mechanical lesion
produced by a needle (30 G) stereotaxically introduced through
the rostral cerebral cortex.
2. Results
2.1. Expression of CaSR mRNA
A detailed analysis of CaSR expression in the normal rat brain
was performed using in situ hybridization. Cells expressing
CaSR mRNA were scattered throughout almost all the brain
Table 1 – Distribution of CaSRmRNA in the adult rat brain.
Brain regions Density of
labeled cells
Olfactory bulb
Internal plexiform layer +
Anterior olfactory nucleus medial and
posterior part
++
Ventral part +++
Tenia tecta +++
Cerebral cortex +
Hippocampal formation
CA1 and CA3 fields of Ammon's horn +
CA2 field of Ammon's horn +++
Stratum Oriens and stratum radiatum
hippocampus
+
Subiculum ++
Septum
Medial septal nucleus +
Lateral septal nucleus +
Septohippocampal nucleus ++
Septofimbrial nucleus +
Septohippocampal nucleus ++
Nucleus of the horizontal limb
diagonal band
++
Basal ganglia
Caudate–putamen +
Globus pallidus +
Amygdala
Amygdaloid complex +
Amygdalohippocampal area +++
Thalamus
Ventrolateral thalamic nucleus +
Ventral posteromedial thal. nu. +
Ventral posterolateral thal. nu. +
Habenular nuclei +
Hypothalamus
Paraventricular hypoth. nu.,
medial parvicell.
++
Anterior medial preoptic nu. ++
Medial preoptic nu. ++
subfornical organ ++++
Arcuate hypoth nu. ++
Lateral hypothalamic area +
Dorsal hypoth area ++
Dorsomedial hypoth. nu. +
Dorsomedial hypoth. nu. compact ++
Premammillary nu., ventral part +
Lateral mammillary nu. ++
Tuberomammillary nu.ventral part ++
Periventricular hypoth. nu. ++
Mammillothalamic tract ++
Suprachiamatic and supraoptic nu. +
Tuber cinereum area ++
Ventromedial hypoth. Nu +
Mesencephalon +
Interpeduncular nu. +
Geniculate nu. +
Inferior and superior colliculus +
Central gray +
Table 1 (continued)
Brain regions Density of
labeled cells
Cerebellum
Cerebellar cortex +
Cerebellar nu. +
Brain stem
Several nuclei and fibers tract +
Dorsal nu. of lateral lemniscus +++
Dorsal tegmental bundle ++
Area postrema ++
White matter
Forceps major ++
Forceps minor ++
Cingulum +
Fimbria hippocampus ++
Fornix +
Stria terminalis ++
Internal and external capsule +
Medial forebrain bundle ++
Commissure +
Corpus callosum ++
Dorsal root ganglia +++
Spinal cord +
Relative density of CaSR mRNA expressing cells: (+) low, (++)
moderate, ( +++) high, ( ++++) highest. The data are shown using an
arbitrary semiquantitative scale of labeling density described as
‘‘low density of labeling’’ (+), indicating the percentage of labeled
cells between 5 and 20%; as ‘‘moderate density of labeling’’ (++),
indicating the percentage of labeled cells between 20 and 40 %;
and as ‘‘high density of labeling’’ (+++), indicating the percentage
of labeled between 40 and 80 %; and “highest density of labeling’’
( ++++) indicating the percentage of labeled between 80 and 100%.
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areas with regional differences in labeled cells density. Brain
regions and nuclei that express CaSR mRNAs are listed in
Table 1, that report the relative density of CaSR-expressing
cells ranked on a scale from one to four, with “+” representing
widely scattered cells (5-20%) and “++++” representing the
highest cell density (80–100%). Figs. 1–3 show representative
brain regions and nuclei expressing CaSR mRNA. The speci-
ficity of CaSR in situ hybridization assays was determined by
the use of a sense strand control probe (Fig. 4) and by using as
positive control the thyroid tissue in which CaSR mRNA is
selectively expressed in the parafollicular C cells (data not
shown).
Fig. 1 – Autoradiophotograms in dark (A–D) and bright (A1–D1) field showing the CaSR mRNA expression in various brain
regions: CA2 and CA3 pyramidal layers of the hippocampal region (A–A1); CTX, cerebral cortex (B–B1); CPu, caudate–putamen
(C–C1); DRG, dorsal root ganglia (D–D1); Arrows indicate cells expressing CaSR mRNA. Scale bar: (A, B) 300 μm; (C, D) 200 μm;
(A1–B1) 25 μm; (C1–D1) 50 μm.
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2.2. Colocalization of CaSR mRNA in neurons and glial
cells
The double labeling analysis by in situ hybridization for
CaSR mRNA and immunohistochemistry for specific cel-
lular markers (NeuN, GFAP, CNPase and CD11b), allowed
us to identify the cell types expressing CaSR. Neurons,
identified as NeuN-positive cells, show CaSR expression in
several brain regions (Fig. 5). In all the brain regions
examined, the double labeling analysis shows a localization
Fig. 2 – Autoradiophotograms in dark (A–D) and bright (A1–D1) field showing the CaSR mRNA expression in various brain
regions riches in neuronal fibers: fmj, forceps major of the corpus callosum (A-A1); fmi, forceps minor of the corpus
callosum (B–B1); ic, internal capsule (C–C1); fi and st, fimbria of the hippocampus and stria terminalis respectively (D–D1).
CPu, caudate–putamen. Arrows indicate cells expressing CaSR mRNA. Scale bar: (A–C) 200 μm; D 300 μm (A1–C1) 50 μm.
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of CaSR mRNA in oligodendrocytes, identified as CNPase-
positive cells (Fig. 6). By contrast, CaSR mRNA is not ex-
pressed both in the microglia, identified as CD11b-positive
cells and in astrocytes, identified as GFAP-positive cells
(Fig. 6).
2.3. Expression of CaSR mRNA following brain lesion
To define the regulation of CaSRmRNA expression in response
to brain injury an in situ hybridization study was performed at
different time points (24 h, 48 h, 72 h and 1 week). We used
Fig. 3 – Autoradiophotograms in dark (A–D) and bright (A1–D1) field showing the CaSR mRNA expression in various
brain nuclei: AHi, anterior hypothalamic area (A–A1); AP, area postrema (B–B1); DMC, dorsal hypothalamic nucleus,
compacta part (C–C1); TT, tenia tecta (D–D1). Arrows indicate cells expressing CaSR mRNA. Scale bar: (A–D) 200 μm;
(A1–D1) 50 μm.
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three different experimental brain lesions: Kainate-induced
seizure, Ibotenic acid-induced lesion and mechanical lesion
induced by needle insertion.
2.3.1. Kainate-induced seizure
The seizure induced by intracerebroventricular kainic acid
injection produced a neuronal death mainly in the CA3 pyra-
midal layer of the hippocampus and consequently an activa-
tion of gliosis in this hippocampal region (Belluardo et al., 1996).
At early post-injury times (24, 48, 72 h) no changes in CaSR
expression were detected. At 1 week post-injury two different
phenomena were observed (Fig. 7 and Table 2): (1) the appear-
ance of several labeled non-neuronal cells in the injured CA3
region; (2) an increase of the amount of hybridization grains per
cells andnumber of labeled cells in theCA1–CA3 subfield and in
the dentate gyrus of hippocampal formation.
2.3.2. Ibotenic acid-induced hippocampal injury
We also examined the CaSR mRNA expression at different
time points after unilateral injection in the dorsal hippo-
campal formation of ibotenic acid, a neurotoxin with excito-
toxic properties (Condorelli et al., 1988). In the lesioned area
we observed an increased number of non-neuronal CaSR
mRNA expressing cells 1week following ibotenic acid injec-
tion (Fig. 7 and Table 2). These cells were localized both
inside and along the border of the lesioned area and showed
a scattered distribution (Fig. 7). Interestingly, 1 week after
unilateral injection of ibotenic acid, an increased CaSR ex-
pression was also observed in the contralateral CA1–CA3
pyramidal cell layers and in the dentate gyrus involving both
the percentage of labeled cells and the grain density per cell
(Fig. 7 and Table 2).
2.3.3. Mechanical injury in the cerebral cortex and in the
corpus callosum
We performed a mechanical lesion by insertion of a needle in
the cerebral cortex and in the underlying corpus callosum at
the rostral caudate–putamen level. In the control rat, the CaSR
mRNA was expressed in scattered cells both in the cerebral
cortex and in the corpus callosum. One week after mechanical
lesion an increased density of labeled cells expressing CaSR
mRNA was observed along the needle track both in the
cerebral cortex and in the corpus callosum (Fig. 7 and Table 2).
2.4. Identification of CaSR mRNA expressing cells in the
area of lesion
To identify the non-neuronal cell type expressing CaSRmRNA
in the injured area we performed a double labeling analysis
using specific markers for glial cells. This analysis showed, in
all experimental models of brain lesion used, a localization of
CaSR mRNA in CNPase-positive cells. Representative images
of this result in ibotenic acid-induced lesion are shown in
Fig. 8.
3. Discussion
Results regarding the brain distribution of CaSR transcripts
are in agreement with data of previous works (Ferry et al.,
2000; Rogers et al., 1997) confirming an expression of CaSR in
all brain regions, with a particularly high abundance in
subfornical organ, olfactory bulb and hypothalamus. Howev-
er, we observed different intensity of signal in some brain
regions or nuclei (e.g. hippocampal layers, hypothalamus
nuclei) in comparison to previously reported data (Rogers et
al. 1997). Such minor discrepancies might be related to the
lower length of riboprobe (627 bp) used in the present work as
compared to that (1.2 kb) used by Rogers et al. (1997) or to in
situ hybridization procedure efficacy. A feature of cells
expressing CaSR mRNA was their scattered distribution in
mostly brain regions, suggesting the possibility that this
receptor is expressed in a neuronal or oligodendroglial
network with a key role for extracellular calcium sensing.
This could be the case of CaSR expression in the white matter
for oligodendroglial cells or in the cerebral cortex and in the
striatum for neurons. By contrast, some brain nuclei showed
very high levels of CaSR mRNA suggesting a role of CaSR in
region-specific neuronal functions, such as in the subfornical
organ for the regulation of ionic calcium levels in the blood
(Sibbald et al., 1988) or in the area postrema for autonomic
control of several physiological systems, including the
cardiovascular system and the systems controlling feeding
and metabolism (Fry and Ferguson, 2007). However, the CaSR
present in neuronal cells could potentially contribute to the
control of Ca2+ levels, which in turn are involved in a variety of
neuronal functions, such as signal transduction, generation
Fig. 4 – Photomicrograph from film autoradiogram of CaSR mRNA expression in the adult rat brain. Representative view of
sagittal brain section at lateral level L 2.40 mm, according to Paxinos and Watson Atlas. CTX, cerebral cortex; Cpu,
caudate–putamen; Hip, hippocampus; Hy, hypothalamus; OB, olfactory bulbs; Cb, cerebellum; Sense, brain section hybridized
with sense probe. Scale bar, 5 mm.
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and propagation of action potentials, and neurotransmitter
release. On this regard, immunohistochemistry has revealed
a localization of CaSR within nerve terminals, suggesting that
CaSR may regulate neurotransmitter synthesis or release in
response to Ca2+ levels in the synaptic space and therefore
may modulate synaptic responsiveness and plasticity (Jinno
et al., 2002; Ruat et al., 1995; Rusakov and Fine, 2003; Vassilev
et al., 1997).
Fig. 5 – Analysis of cell type-expressing CaSR mRNA in various brain regions. Autoradiophotograms from coronal sections
showing in high magnification that CaSR mRNAs colocalize with the neuronal marker NeuN. CTX, cerebral cortex; CPu,
caudate–putamen; AHi, Anterior hypothalamic area; CA2 pyramidal layer of the hippocampus; MPOM,medial preoptic nucleus
medial part; HDB, nucleus of the horizontal limb of diagonal band; Am, amygdala nucleus; PaMP, paraventricular hypothalamic
nucleus,medial parvicellular part. Arrows indicate CaSR/NeuN double labeled cells. Arrowhead indicate clusters of CaSRmRNA
grains that did not colocalize with NeuN. Scale bar: 50 μm.
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Themain goal of present work was to identify CaSRmRNA-
expressing cells in the rat brain and to study the effects of brain
injury on CaSR mRNA expression. Using a double labeling
method, we could confirm that CaSR is expressed both in
neuronal and non-neuronal cells and among the latters we
could show that CaSR is expressed in oligodendrocytes, but not
in microglia and astrocytes. However, in a given brain region
not all oligodendrocytes express CaSR mRNA, suggesting that
this receptor is localized in a subset of these cells. In the
present work, CaSR expression in the oligodendrocytes is in
agreement with previous data (Ferry et al., 2000), whereas the
absence of CaSR in astrocytes and microglia is not (Chatto-
padhyay et al., 1999, 2000). It is noteworthy that although in an
earlier study Chattopadhyay and Brown (2000) failed to detect
expressionof theCaSR inprimary culture of astrocytes isolated
from rat brain, later these and others authors demonstrated
the presence of CaSR mRNA and protein in primary human
astrocytes (Chattopadhyay et al., 2000; Dal Pra et al., 2005). The
function of the CaSR in normal oligodendroglial cells is
currently unknown, but it is reasonable to hypothesize a role
in sensing and regulating local ionic homeostasy during
neuronal activity. CaSR has been linked to modulation of the
activities of at least two types of ion channels, non selective
cation channels and Ca2+-activated K+ channels, and glial cells
may control neuronal excitability by regulating extracellular K+
(Vassilev et al., 1997). The CaSR present in oligodendroglial
cells could potentially contribute to other functions since
regulation of the extracellular calcium concentration is crucial
for numerous cellular processes that include maintenance
of membrane potential and control of cellular proliferation,
Fig. 6 – Analysis of cell type-expressing CaSR mRNA in various brain regions. Autoradiophotograms from coronal sections
showing in high magnification that CaSR mRNAs colocalize with oligodendroglial marker CNPase: CTX, cerebral cortex; cc,
corpus callosum; CPu, caudate–putamen; Hyp, hypothalamus. In contrast, CaSR mRNA does not colocalize with GFAP and
CD11b markers for astrocytes andmicroglia, respectively, as shown in representative sections of cerebral cortex (CTX). Arrows
indicate CaSR/CNPase double labeled cells. Arrowhead indicate clusters of CaSR mRNA grains that does not colocalize with
GFAP and CD11b markers. Scale bar: 50 μm.
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differentiation and secretion (Brown and MacLeod, 2001;
Chattopadhyay et al., 1998).
Although the expression of CaSR has largely been studied
in normal condition, no data have been reported for CaSR
expression in injured brain. Using threemodels of brain lesion
we could detect in the injured area an increase of CaSRmRNA-
expressing cells, that have been identified as oligodendrocytes
and not as astrocytes or microglia. A feature of CaSR ex-
pression following brain injury was its delayed appearance
(7 days post-lesion) in the area of damage, even if the glial
reaction (reactive gliosis) can be already observed after two
days. In addition, in the area of gliosis not all the CNPase-
positive oligodendroglial cells express CaSRmRNA, suggesting
the involvement of a subset of oligodendrocytes in the func-
tion of Ca2+ sensing cells. The delayed response of CaSR ex-
pression to brain injury could be related to a local extracellular
environmental signals with a critical role in the gliotic tissue
organization. In addition to the glial expression in the dam-
aged area, we observed also a clear increase in the level of
CaSR mRNA in neuronal cells. The delayed up-regulation of
CaSR mRNA in the CA1–CA2 and the dentate gyrus of
hippocampal formation following seizure-induced by kainate
treatment could depend on modification of neuronal activity
or on reduced levels of Ca2+ in the local microenvironment.
According with this possibility, in some brain conditions
characterized by increased neuronal activity and in certain
pathological states such as seizures, ischemia, and hypogly-
cemia, Ca2+ levels within the extracellular fluid of the brain are
reduced and could potentially be sensed by CaSR (Heinemann
et al., 1977).
CaSR displays significant homology with metabotropic
glutamate receptors (mGluRs) expressed in the brain
(Nakanishi, 1992; Ruat et al., 1995), and it has been shown
that some types of mGluRs, including mGluR3 and mGluR5,
are activated not only by glutamate but also by extracellular
Ca2+ (Kubo et al., 1998), although the physiological relevance of
this Ca2+-sensing property remains unknown. Interesting,
similarly to CaSR, in a previous work we found an increased
expressionofmGluR3andmGluR5oneweekafter ibotenic acid
or kainate-induced lesions in the rat brain. Such expression
changes were localized in oligodendroglial cells or in neurons
of dentate gyrus and CA1 pyramidal cell layer (Mudo et al.,
2007). Therefore, Ca2+ sensing ability by both mGluRs and CaSR
in the area of lesion suggests a relevant role of extracellular Ca2+
for regulationof cellular processes in response to braindamage
(Verkhratsky and Kettenmann, 1996).
In conclusion, the present results contribute to extend
available data on CaSR expressing cell types in normal and
injured brain and spur-renewed interest on the role of CaSR
and other calcium sensing receptors in repairing processes
after brain injury.
4. Experimental procedures
Wistar adult male rats (250 g b.w.) from local stock have been
used for the present study. The ratswere kept under controlled
temperature and standardized lighting and free access to food
and water. Procedures involving animals and their care were
conducted in conformity with the institutional guidelines that
are in compliance with national and international laws and
policies. All efforts were made to minimize the number of
animals used and their suffering and all experiments were
approved by the local ethical committee
4.1. Brain lesion
The CaSR mRNA expression was studied in three models of
brain injury leading to reactive gliosis: (1) ibotenic acid
injection in the dorsal hippocampus as described in Condor-
elli et al. (1988); (2) epilepsy induced by kainic acid injection in
the lateral ventricle as described in Mudò et al. (1995); (3)
mechanical lesion produced by a needle (30 G) stereotaxically
introduced through the rostral cerebral cortex until it entered
in the striatum for 1 mm as described in Cheng et al. (2008).
Ibotenic acid (Sigma Chem. Co St. Louis, MO) was dissolved in
phosphate buffered saline (PBS), 0.05 M final concentration,
and pH adjusted to 7.2 with NaOH and injected at a volume of
0.5 μl in the right dorsal hippocampus. Rats treated with
kainic acid (Sigma, St. Louis, MO) were injected bilaterally in
the brain lateral ventricle (0.35 μg/0.5 μl PBS). For the lesions,
the rats were anesthetized with chloral hydrate and a David
Kopf stereotaxic apparatus was used for drug injection and
mechanical lesion according the following coordinates (Pax-
inos andWatson, 1999): for ibotenic acid injection, Bregma: AP
4.16 mm, V 4.2 mm, L 1.9 mm; for kainic acid injection,
Bregma: AP +0.2, L 1.5, V 4.2; for mechanical lesion Bregma:
AP, +1.20 mm; V, 4 mm; L, 1.5 mm. At different time from the
brain lesion (24 h, 48 h, 72 h and 1 week) the rats (three for
each group) were killed by decapitation under deep anesthe-
sia and brains were frozen in cooled isopentane and stored at
−70 °C until use.
4.2. In situ hybridization
In the present study we examined by in situ hybridization the
gene expression of CaSR in both normal condition and
following brain injury.
Fig. 7 –Autoradiophotograms in dark field (A–D) showingCaSRmRNAexpression in thehippocampal formation in the following
condition: in control rat (A) and in rat 1week after injection of kainate-induced seizures (B); in rat 1week after unilateral injection
of ibotenic acid-induced lesion (C–D), respectively, in the unlesioned (contra) and lesioned (ipsi) side of hippocampal formation.
Note the increased levels of CaSRmRNAexpression in thehippocampal CA1–CA3pyramidal cell layers anddentate gyrus (DG) of
kainate treated rat (B) and in the contralateral hippocampus (contra) of ibotenic injected rats. Autoradiophotograms in dark field
(E, I) and in bright field (F, J) showing CaSR mRNA expression in the area of lesion 1 week after unilateral intrahippocampal
ibotenic acid injection (E–F) or in the area of needle insertion-inducedmechanical lesion (G–H), and (I, J) brain section hybridized
with sense probe respectively in the hippocampus of ibotenic lesion and in the cerebral cortex of needle lesion. The arrows
indicate cells positive for CaSR mRNA expression. Scale bar: (A–D) 300 μm; (E, I) 200 μm; (F, J) 50 μm.
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A 628-bp fragment, encompassing nucleotides 3168-3795
(GenBank accession number NM_016996) for CaSR, DNA
fragments were separated by electrophoresis, recovered
from agarose gel with the GeneClean II Kit (Bio 101, CA),
subcloned in pCR-Script SK (+) (Stratagene La Jolla, CA, USA).
The recombinant plasmids were then linearized with EcoR1
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and transcribed with T3 RNA polymerase for the antisense
probes. To obtain the sense probes, the same plasmids were
linearized with Sac1 and transcribed with T7 RNA polymerase.
For transcription template was incubated 60min at 37 °C in
the presence of a transcription buffer made of 40 mM Tris–HCl
pH 7.5, 6 mMMgCl2, 2 mM spermidine and supplemented with
12.5 nmol ATP, CTP andGTP, 500 pmol UTP and 125 pmol 35S α-
UTP (Perkin-Elmer Italia, cod. NEG039H), 1 IU/μl RNAse
inhibitor and 1 IU/μl of specific polymerase. The cDNA
template was digested by adding 20 ng/ml DNAse I at 37 °C
for 30 min. Transcripts were purified using ProbeQuant
columns (ProbeQuant™ G-50 Micro Columns, cod. 27533501,
GE Healthcare Europe GmbH). Control of the hybridization
specificity of the cRNA riboprobes was performed using sense
35S-labeled riboprobes.
Serial brain coronal cryostat sections of 14 μmwere thawed
onto 3-aminopropyl ethoxysilane-coated slides for in situ
hybridization with radiolabeled probes as follows. Following
Fig. 8 – Analysis of cell type-expressing CaSR mRNA in the injured area 1 week after unilateral intrahippocampal ibotenic acid
injection. Autoradiophotograms from coronal sections showing in high magnification that in the area of lesion CaSR mRNA
colocalize with CNPase marker (arrows) and does not colocalize with NeuN, GFAP or CD11b markers (Arrowhead). Scale bar:
30 μm.
Table 2 – Relative CaSR mRNA levels per cell, and percentage of cells expressing CaSR mRNA in the cerebral cortex and
hippocampal formation of rat brain 1 week post-injury.
Brain regions % of CaSR mRNA labeled cells Grains density per cell
Control Ibotenic
Contraa
Kainate Needle Control Ibotenic
Contraa
Kainate Needle
Cerebral Cortex 6.8±2.5 – – 14.2±3.4
P<0.01
124.8± 18 55.8±7.3
P<0.00001
CA1 pyramidal layer 15±3.8 47.2±10.3
P<0.001
45±9.7
P<0.001
– 5±2.5 12.2±3.9
P<0.01
9±2.6
P<0.05
_
CA2 pyramidal layer 51.6±5.7 64.4±7.8
P<0.002
60±2.9
P<0.002
– 50±4.1 75±9.3
P<0.001
72.2±7.2
P<0.001
_
CA3 pyramidal layer 17.4±3.6 32.6±7.5
P<0.01
31.8±4.6
P<0.001
– 4.2±1.3 12±3.1
P<0.001
10.2±4.3
P<0.02
_
Dentate gyrus 0 25±4 20±2.4 – 0 10±1.8 7±1.2 –
Ibotenic lesioned area 12.7±3.3 35.8±7.4
P<0.001
– 38.2±4.4 51±8.3
P<0.02
– –
The relative CaSR mRNA levels and the percentage of cells expressing CaSR mRNA have been evaluated as described in material and methods.
a Ibotenic contra indicates the contralateral hippocampal formation to lesioned one. Statistical analysis of Means±SD. The data were evaluated
by t-test.
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fixation in 4% paraformaldehyde for 15 min, slides were rinsed
twice in PBS and once in distilled water. Tissue was deprotei-
nated in 0.2 M HCl for 10 min, acetylated with 0.25% acetic
anhydride in 0.1 M ethanolamine for 20 min and dehydrated
with increasing concentrations of ethanol. Slides were incubat-
ed 16 h in a humidified chamber at 52 °C with 8×105 cpm of
probe in 70 μl hybridization cocktail (50% formamide, 20 mM
Tris–HCl (pH 7.6), 1 mM EDTA pH 8.0, 0.3 M NaCl, 0.1 M
dithiothreitol, 0.5 mg/ml yeast tRNA, 0.1 mg/ml poly-A-RNA,
1× Denhardt's solution and 10% dextran sulfate). Slides were
washed twice in 1×SSC at 62 °C for 15 min and then in
formamide and SSC (1:1) at 62 °C for 30 min. After an additional
washing in 1×SSCat 62 °C, single-strandedRNAwasdigestedby
RNAse treatment (10 mg/ml) for 30 min at 37 °C in 0.5 M NaCl,
20 mM Tris–HCl pH 7.5, 2 mM EDTA. Tissue was washed twice
with 1×SSC at 62 °C for 30 min before dehydration in ethanol
and air-drying. For regional localization of mRNA, hybridized
sections were exposed for 3 weeks to BioMax MR Film (Kodak,
cod 891 2560) and subsequently coatedwith Emulsion TypeNTB
(Kodak, cod. 8895666) diluted 1:1 in water, stored in desiccated
light-tight boxes at 4 °C for 4 weeks. Slides were developed with
D19 (Kodak, cod. 1464593), fixed with Kodak Fixer (Kodak, cod.
1971746) and counterstained with cresyl violet, rinsed in PBS,
dehydrated through graded alcohols, cleared in xylene, and
cover-slipped in DPXmountant.
4.3. Double labeling by combining in situ hybridization for
CaSR mRNA with immunolabeling for neuronal and
non-neuronal cell markers
We have used a combination of in situ hybridization and
immunohistochemical technique to identify the cellular
type-expressing CaSR mRNA in the rat brain. The rats
under deep anesthesia were perfused through the aorta
with 0.9% saline followed by perfusion fixation with 0.1 M
phosphate buffer (pH 7.4) containing 4% paraformaldehyde
and 0.2% picric acid. Brains were removed, post-fixed in the
same fixative for 2 h, and then transferred into 10% sucrose
in 0.1 M phosphate buffer (PBS), overnight at 4 °C. Brain
coronal cryostat sections of 20 μm thick were thawed onto 3-
aminopropyl ethoxysilane- and gelatin-coated slides. Immu-
nohistochemistry labeling was performed immediately after
the last washing of the in situ hybridization procedure.
Sections were washed with PBS and incubated for 15 min in
blocking buffer consisting of 2.5% normal goat serum and
0.3% Triton X-100 in PBS. Subsequently, sections were
incubated overnight at 4 °C in the presence of the primary
antibody diluted in PBS supplemented with 1.5% blocking
serum. The following mouse monoclonal antibodies (Che-
micon, Temecula, CA, USA) and dilutions were used: (a) anti-
neuron-specific DNA-binding protein (anti-NeuN, cod.
MAB377) diluted 1:500; (b) anti-glial fibrillar acid protein
(anti-GFAP, cod. MAB360) diluted 1:500, anti-2′3′-cyclic nu-
cleotide 3′-phosphohydrolase (anti-CNPase, cod. MAB326);
anti-rat integrin-aM (anti-CD11b, cod. MAB1405) diluted
1:200. Sections were then washed three times for 5 min in
PBS and incubated at room temperature for 1 h with a
biotinylated antimouse antiserum processed as per the
Vectastain Universal Quick Kit (PK-8800), and developed
with diaminobenzidine (DAB, #K3468; Dako). The reaction
was stopped in Tris–HCl buffer and after a short washing
with H2O, the sections were dehydrated in an ascending
alcohol series, coated in NTB emulsion and processed as
described above for autoradiographic development.
4.4. Quantitative evaluation of labeled cell
The number of labeled cells was estimated by counts made by
sampling in three representative sections the area of interest
(identified according to the atlas of Paxinos andWatson, 1999).
All cells inside of selected area were counted and therefore
evaluated the percentage of labeled cells. All the counts were
carried out in a double blind manner and by mean of
computerized image analysis software (IAS-Counter, Delta
Sistemi, Rome, Italy). Computerized image analysis was
performed using software coupled to a Leica microscope
equippedwith digital video camera (Spot-RT Slider, Diagnostic
Instruments, Mi, USA).
The labeling and the relative levels of mRNA expression
(intensity) per cells were evaluated from emulsion dipped
slides by evaluation of silver grains over the individual cells,
using image analysis system (IAS-Counter, Delta-Sistemi,
Roma, Italy). A correction factor for overlapping grains was
included. For each brain area examined, the grains of cells in
three different sections were counted. Cells were considered
positive when the amount of silver grains after subtraction of
background was exceeding 5 grains.
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